Busra Demir CENDEK, Filiz Ayse AVSAR, Ozlem SARICI, Aylin Kılıç YAZGAN, Ali İPEK, EVRİM BOSTANCI ERGEN

Sezaryenlerde Plasentanın Myometrium ile İlişkisinin Değerlendirilmesi

Amaç: Günümüzde görülme sıklığı rölatif olarak artmış olan plasental yapışma anomalileri (PYA) tiplerine göre ciddi komplikasyonlara yol açmakta, doğum öncesi invazyon varlığının belirlenmesi ve tipinin açıklanması doğumu gerçekleştirecek hekim açısından büyük önem taşımaktadır. Bu prospektif, kesitsel ve tanımlayıcı çalışmanın amacı, en az bir kez sezaryen (C/S) olmuş ve tekrar C/S planlanan hastalarda preoperatif gri skala ve doppler USG ile PYA açısından değerlendirip histopatolojik tanı ile karşılaştırmaktır.Gereç ve Yöntemler: Bu amaçla Ocak 2013-Temmuz 2013 tarihleri arasında, Yıldırım Beyazıt Üniversitesi Tıp Fakültesi Ankara Atatürk Eğitim Araştırma Hastanesi Kadın Hastalıkları ve Doğum bölümüne başvuran, daha öncesinde en az bir kez C/S olan ve bu gebeliğinde de C/S planlanan toplam 104 olgu çalışma kapsamına alınmıştır. Bu gebelere preoperatif PYA'nın belirlenmesi amacıyla gri skala ve doppler USG yapılıp, intraoperatif plasental yatak biyopsisi alınarak histopatolojik inceleme ile karşılaştırılmıştır.Bulgular: C/S endikasyonlarının %74'ü bir kez C/S, %25,5'i iki kez C/S ve %1'i ikiden fazla C/S'dir. Hastaların hiçbirinde intraoperatif PYA şüphesi, postoperatif komplikasyon ve patoloji sonucunda da PYA rastlanmamıştır. %77,9 hastada doppler USG normal çıkmıştır. %20,2'sinde yalnızca subplasental alanda vaskülarite artışı, %1,0'inde subplasental alanda vaskülarite artışı ve laküner akım varlığı, %1,0'inde yalnızca laküner akım varlığı görülmüştür. Gri skala USG'de %90,4 hastada herhangi bir bulguya rastlanmamıştır. %2,0'sinde plasental lakün ve retroplasental berrak alan obliterasyonu, %7,6'sında plasental alandaki en ince miyometriyal kalınlığın

Determination of Placenta-Myometrium Relationship in Caesarian Sections

Objective: The relative prevalence of placental attachment abnormalities (PAA) has been increased lately. They may cause severe complications in respect to their types, and determining presence and the type of the invasion before delivery is important for the obstetrician. The objective of this prospective, cross - sectional and descriptive study was to investigate PAA preoperatively using gray scale and Doppler ultrasonography (USG) in patients who had a Caesarian section (C/S) at least once before and scheduled for C/S again, and to compare the results with histopathological diagnosis.Material and Methods: A total of 104 pregnant women who admitted to Yıldırım Beyazıt University Medical Faculty, Atatürk Education and Research Hospital Obstetrics and Gynecology Department between January and July 2013, and scheduled for C/S were included in the study. All of the included patients had had C/S before, at least once. Gray scale and Doppler USG was performed in all patients to determine PAA, and the findings were compared with the histopathologic results of placental bed biopsy obtained during C/S.Results: The indications for C/S were previous C/S once in 74%, previous C/S twice in 25.5%, and previous C/S more than twice in 1% of the patients. None of the patients had any suspicion for PAA intraoperatively, postoperative complications, or PAA in the histopathological diagnosis. There were no findings on Doppler USG in 77.9% of the patients, 20.2% of them had increased vascularity alone, 1.0% had increased vascularity and lacunar flow, and 1.0% had lacunar flow alone in the subplasental region. There were no findings on gray scale USG in 90.4% of the patients. There were placental lacunae and obliteration of the retroplacental clear zone in 2.0% of the patients, and the thinnest myometrial wall was <1 mm in the placental region in 7.6% of them.Conclusion: Absence of PAA in our series may be due to factors such as our surgical technique, and individual wound healing processes. The mechanisms causing abnormal placentation are not still clear.

PDF

___

1. Haris RD, Cho C, Wells WA. Sonography of the plasenta with empasis on patological correlation. Semin Ultrasound CT MR 1996;17: 66-89.
2. Doumouchtsis SK, Arulkumaran S. The morbidly adherent placenta: an overview of management options. Acta Obstet Gynecol Scand 2010;89: 1126-1133.
3. Brosens JJ, Pijnenborg R, Brosens IA. The myometrial junctional zone spiral arteries in normal and abnormal pregnancies. Am J Obstet Gynecol 2002;187: 1416-1423.
4. Lam G, Kuller J, McMahon M. Use of magnetic resonance imaging and ultrasound in the antenatal diagnosis of placenta accreta. J Soc Gynecol Investing 2002;9: 37-40.
5. JM Palacios-Jaraquemada. Diagnosis and management of placenta accreta. Best Practice & Research Clinical Obstetrics and Gynaecology 2008;22: 1133-1148.
6. E. Jauniaux, D. Jurkovic. Placenta accreta: Pathogenesis of a 20th century iatrogenic uterine disease. Placenta 2012; 33(4): 244-251.
7. Gielchinsky Y, Rojansky N, Fasouliotis SJ, Ezra Y. Placenta acreta-summary of 10 years: a survey of 310 cases. Plasenta 2002; 23 (2-3): 210-4.
8. Bauer ST, Bonanno C. Abnormal placentation. Semin Perinatol 2009;33(2): 88-96.
9. Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol 2005;192(5):1458-61.
10. Hull AD, Moore TR. Multiple repeat cesareans and the threat of placenta accreta: incidence, diagnosis, management. Clin Perinatol 2011; 38(2): 285-96.
11. Wong HS, Cheung YK, Zuccollo J, Tait J, Pringle KC. Evaluation of sonographic diagnostic criteria for placenta accreta. J Clin Ultrasound 2008; 36 (9): 551-9.
12. Eller AG, Bennett MA, Sharshiner M, Masheter C, Soisson AP, Dodson M, et al. Maternal morbidity in cases of placenta accreta managed by a multidisci-plinary care team compared with standard obstetric care. Obstet Gynecol 2011; 117 (2 Pt 1): 33-7.
13. Esh-Broder E, Ariel I, Abas-Bashir N, Bdolah Y, Celnikier DH. Placenta accreta is associated with IVF pregnancies: a retrospective chart review. BJOG 2011; 118(19): 1084-9.
14. Beuker JM, Erwich JJ, Khong TY. Is endomyometrial injury during termination of pregnancy or curettage following miscarriage the precursor to placenta accreta? J Clin Pathol 2005; 58(3): 273-5.
15. Usta IM, Hobeika EM, Musa AA, Gabriel GE, Nassar AH. Placenta previa-accreta: risk factors and complications. Am J Obstet Gynecol 2005; 193 (3 Pt 2): 1045 9.
16. M Kamara, JJ Henderson, DA Doherty, JE Dickinson, CE Pennell. The risk of placenta accreta following primary elective caesarean delivery: a case - control study. BJOG. 2013; 120(7): 879-886.
17. Challis JRG. Mechanism of parturit ion and preterm labor. Obstet Gynecol Surv 2000; 55(10): 650-60.
18. Osman I, Young A, Ledingham MA, Thomson AJ, Jordan F, Greer IA, et al. Leukocyte density and pro-inflammatory cytokine expression in human fetal membranes, decidua, cervix and myometrium before and during labour at term. Mol Hum Reprod 2003; 9(1): 41-5.
19. Khong TY, Robertson WB. Placenta creta and placenta praevia creta. Placenta 1987; 8(4): 399-409.
20. Tantbirojn P, Crum CD, Parast MM. Pathophysiology of placenta creta: the role of deciduas and extravillous cytotrophoblast. Placenta 2008; 29(7): 639-45.
21. Wehrum MJ, Buhimschi IA, Salafia C, Thung S, Bahtiyar MO, Werner EF, et al. Accreta complicating complete placenta previa is characterized by reduced systemic levels of vascular endothelial growth factor and by epithelial-to-mesenchymal transition of the invasive trophoblast. Am J Obstet Gynecol 2011; 204: 411.